European Healthtech startup funding raised during 2013.
In 2013, 108 European Healthtech companies raised a combined €748M across 121 funding rounds. Switzerland led by capital raised, and Sofinnova Partners was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Biotie Therapies | Grant | Jun 2013 | €111M |
| Symphogen | Growth/Late | May 2013 | €41M |
| Auris Medical | Series C | Apr 2013 | €40M |
| Opsona | Series C | Apr 2013 |
| €33M |
| GenSight Biologics | Series A | Apr 2013 | €32M |
| Merus | Series B | Oct 2013 | €31M |
| Evotec | Growth/Late | Sep 2013 | €30M |
| Biocartis | Series D+ | Nov 2013 | €30M |
| ADC Therapeutics | Growth/Late | Oct 2013 | €30M |
| ObsEva | Series A | Aug 2013 | €26M |
| MISSION Therapeutics | Series B | Nov 2013 | €24M |
| WiThings | Series B | Jul 2013 | €23M |
| STAT-Diagnostica | Series B | May 2013 | €22M |
| CeQur | Series B | Sep 2013 | €20M |
| Genticel | Series D+ | Apr 2013 | €18M |
